Opioid Overdose Rescue and Prevention System

Publication ID: 24-11857547_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Opioid Overdose Rescue and Prevention System,” Published Technical Disclosure No. 24-11857547_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857547_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,547.

Summary of the Inventive Concept

A comprehensive system for opioid overdose rescue and prevention, leveraging the core technology of the original patent to address the opioid epidemic through innovative applications and use cases.

Background and Problem Solved

The original patent relates to pharmaceutical compositions for rescuing a subject from an opioid overdose. However, the opioid epidemic requires a more comprehensive approach, including detection, treatment, and prevention. The new inventive concept addresses these limitations by applying the core technology to entirely new fields, such as wearable sensors, mobile applications, and population monitoring.

Detailed Description of the Inventive Concept

The system comprises a wearable sensor that detects opioid overdose in a subject, triggering a mobile application to alert emergency services. Additionally, the system includes a portable device for opioid overdose rescue, containing a parenteral formulation according to the original patent and an instructional module. Furthermore, the system features a population monitoring component, utilizing a database of opioid prescriptions and a machine learning algorithm to identify high-risk individuals and alert healthcare providers. The system also encompasses a method for treating opioid withdrawal, combining the opioid antagonist formulation with cognitive behavioral therapy.

Novelty and Inventive Step

The new claims introduce entirely novel applications and use cases for the core technology, including wearable sensors, mobile applications, and population monitoring. These innovations provide a non-obvious solution to the opioid epidemic, addressing the limitations of the original patent and expanding its reach to new fields.

Alternative Embodiments and Variations

Alternative embodiments may include integrating the wearable sensor with other health monitoring devices, developing a virtual reality platform for cognitive behavioral therapy, or incorporating artificial intelligence into the population monitoring component. Variations may include adapting the system for use in different demographics or geographic regions.

Potential Commercial Applications and Market

The Opioid Overdose Rescue and Prevention System has significant commercial potential in the healthcare and pharmaceutical industries, targeting markets such as emergency medical services, substance abuse treatment centers, and healthcare providers. The system's innovative approach to addressing the opioid epidemic positions it for widespread adoption and significant revenue growth.

Field of Art

Pharmaceutical formulations, medical device systems, and opioid antagonist delivery technologies, requiring advanced knowledge in pharmacology, medical device design, and clinical intervention strategies

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in pharmaceutical sciences or biomedical engineering, experienced in drug delivery systems, medical device development, and clinical intervention technologies, with expertise in opioid pharmacology and emergency medical response

Obviousness Rationale

A PHOSITA would recognize that the source patent's nalmefene formulation provides a foundational technology that can be readily extended into comprehensive overdose prevention and intervention systems. The technical principles of rapid opioid antagonist delivery inherently suggest broader applications in emergency response, patient monitoring, and public health interventions. The disclosed variations represent predictable combinations of known medical technologies that would be obvious to implement given the existing pharmaceutical and medical device knowledge.

Obvious Combinations & Variations

Source Patent Element
Parenteral nalmefene formulation with rapid plasma concentration delivery
PTD Variation
Integrating the formulation with a wearable sensor and mobile alert system for overdose detection
Obviousness Reasoning
Combining drug delivery with monitoring technologies is a predictable solution in emergency medical interventions, representing a known technique for enhancing patient safety
Source Patent Element
Opioid antagonist pharmaceutical composition
PTD Variation
Developing a portable rescue device with integrated instructional module for first responders and public use
Obviousness Reasoning
Simplifying complex medical technologies for broader accessibility is a standard design approach in emergency medical products, representing an obvious extension of existing pharmaceutical innovations
Source Patent Element
Nalmefene as an opioid antagonist for overdose intervention
PTD Variation
Implementing machine learning population monitoring to identify high-risk individuals
Obviousness Reasoning
Applying data analytics to pharmaceutical intervention strategies is a predictable technological progression in public health management
Source Patent Element
Pharmaceutical method for opioid antagonist delivery
PTD Variation
Combining pharmacological intervention with cognitive behavioral therapy for withdrawal treatment
Obviousness Reasoning
Holistic treatment approaches integrating pharmaceutical and psychological interventions are well-established in medical practice, representing an obvious combination of known therapeutic techniques
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857547, the present publication demonstrates that the claimed variations in opioid overdose intervention technologies would have been obvious to a person having ordinary skill in the art at the time of invention. The disclosed systems and methods represent predictable combinations of known pharmaceutical, medical device, and data analytics technologies, thereby rendering subsequent claims of novelty invalid under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,547
TitleCompositions and methods for opioid antagonist delivery
Assignee(s)Purdue Pharma L.P.